CARSGEN THERAPEUTICS
CARsgen is a leading clinical-stage immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has partnership with Shanghai Cancer Institute and Shanghai Renji Hospital. The company is leading the first tier of CAR-T development, by completing Worldโs first hepatocellular carcinoma (HCC) and Chinaโs exclusive glioblastoma multiforme (GBM) dose ascending injection tests. Funded by leading venture capital firm BVCF, CARsgen is well-positioned to bring a novel cancer therapeutics to the market in China and worldwide.
CARSGEN THERAPEUTICS
Social Links:
Industry:
Health Diagnostics Medical Therapeutics
Founded:
2014-11-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.carsgen.com
Total Employee:
11+
Status:
Active
Contact:
+862154489928
Email Addresses:
[email protected]
Total Funding:
276 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Font Awesome Global Site Tag Euro Microsoft Exchange Online
Similar Organizations
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
immatics biotechnologies
immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
MabSpace Biosciences
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
VetSource
VetSource is a pharmaceuticals company providing pet care medication and vaccination services.
Current Employees Featured
Founder
Investors List
Loyal Valley Capital
Loyal Valley Capital investment in Series C - CARsgen Therapeutics
South China Venture Capital
South China Venture Capital investment in Series C - CARsgen Therapeutics
Shiyu Capital
Shiyu Capital investment in Series C - CARsgen Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - CARsgen Therapeutics
Summer Capital
Summer Capital investment in Series C - CARsgen Therapeutics
KTB Ventures
KTB Ventures investment in Series C - CARsgen Therapeutics
Jolly Innovation Ventures
Jolly Innovation Ventures investment in Series C - CARsgen Therapeutics
Photon Fund
Photon Fund investment in Series C - CARsgen Therapeutics
Kaitai Capital
Kaitai Capital investment in Series B - CARsgen Therapeutics
JIC Genesis Fountain Healthcare Ventures
JIC Genesis Fountain Healthcare Ventures investment in Series B - CARsgen Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-08-02 | CARsgen Appoints Dr. Hua Jiang as Executive Director |
2022-04-07 | CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer |
2022-01-17 | CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation |
Official Site Inspections
http://www.carsgen.com Semrush global rank: 2.34 M Semrush visits lastest month: 7.95 K
Unable to get host informations!!!